Genomics

Dataset Information

CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma.


ABSTRACT: CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma.

PROVIDER: PRJNA1204309 | ENA |

REPOSITORIES: ENA